pSivida
Follow
Get notifications in MyBN when activity occurs.
pSivida is a leading provider of miniaturised, sustained-release drug delivery products and is continuing the evolution of these systems.
Formerly an ASX-listed company, pSivida's intellectual property portfolio consists of over 150 issued patents in countries including the US, Europe, Japan, China and Australia.
pSivida, a NASDAQ-listed company, is developing products designed to revolutionise treatments, with a primary focus in ophthalmology.
Contact Details
Company Activity
NEWS: Tagged in Entrepreneurial trio keen for more | 16 Jun 2022 |